Case report: Accelerated regression of giant cardiac rhabdomyomas in neonates with low dose everolimus
Cardiac rhabdomyoma (CRHM) is the principal cardiac tumor in children and is most often associated with tuberous sclerosis complex (TSC). Mutations in the TSC1 and TSC2 genes cause the overactivation of the mammalian Target of Rapamycin (mTOR). This protein family is responsible for abnormal cell pr...
Saved in:
Main Authors: | Daniel Hurtado-Sierra (Author), Judy Ximena Ramos Garzón (Author), Lyda Z. Rojas (Author), Oscar Fernández-Gómez (Author), Francisco Manrique-Rincón (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regression of Cardiac Rhabdomyomas in a Neonate after Everolimus Treatment
by: Helen Bornaun, et al.
Published: (2016) -
Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
by: Yuka Shibata, et al.
Published: (2019) -
Symptomatic improvement using everolimus in infants with cardiac rhabdomyoma
by: Bhargavi Dhulipudi, et al.
Published: (2019) -
Efficacy of Everolimus Low-Dose Treatment for Cardiac Rhabdomyomas in Neonatal Tuberous Sclerosis: Case Report and Literature Review
by: Luisa Federica Nespoli, et al.
Published: (2021) -
Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications
by: Eyal Sagiv, et al.
Published: (2022)